immuno-oncologynews.com
Cancer Immunotherapy Based on Engineered Immune Cells as a Promising Approach Against Myeloma
http://immuno-oncologynews.com/2015/07/22/cancer-immunotherapy-based-engineered-immune-cells-promising-approach-myeloma
This is a short description about myself and what this site is about. I hope you enjoy being here! Cancer Immunotherapy Based on Engineered Immune Cells as a Promising Approach Against Myeloma. July 22, 2015. July 22, 2015. By Patricia Silva, PhD. A study recently published in the journal. Revealed that cancer immunotherapy can be successfully employed against multiple myeloma. The study is entitled. NY-ESO-1 specific TCR engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
sparkventuremanagement.com
INVESTMENTS — SPARK
http://www.sparkventuremanagement.com/investments
Simba makes it simple, they make one mattress; the best. Simba mattresses use five layers of luxury, designed from the results of extensive research with The Sleep To Live Institute, which studied more than 10 million people and 180 million body profile data points. Simbas innovative design arrives at your door rolled and packaged so theres no drama in getting it up the stairs! Designed and made in the UK and available from John Lewis. Settled support you to sell your house from start to finish. Dan Coll...
masthercell.com
MaSTherCell - News
http://www.masthercell.com/news
Please rotate your device to portrait mode. Our mission and vision. Behind the Scenes of a MaSTherCell Career. New collaboration with Adaptimmune for T-cells based therapy. We are pleased to announce that we have been selected by Adaptimmune as a supplier of cell therapy products for use in Adaptimmune’s clinical trials. This deal confirms once again MaSTherCell as a key partner for immuno-based cell therapy. MaSTherCell doubles its production capacity. Launch of the construction of five new clean rooms.
eu.arminvestorday.com
Company Presenters | EU Advanced Therapies Investor Day
http://eu.arminvestorday.com/company-presentations
Timothy Miller, Ph.D., President, CEO and Director. Headquarters: Texas, USA. Number of Full-Time Employees: 18. Company Website: www.abeonatherapeutics.com. James Noble, Co-Founder and CEO. Headquarters: Abingdon, UK. Number of Full-Time Employees: 279. Company Website: www.adaptimmune.com. Mike Rice, President and CEO. Headquarters: Washington, USA. Number of Full-Time Employees: 45. Company Website: www.biolifesolutions.com. Linda Marban, Ph.D., Co-Founder and CEO. Headquarters: California, USA. Kiadi...
obn.org.uk
OBN: Supporting the UK’s Innovative Life Sciences Companies | Members Directory
http://www.obn.org.uk/members-directory/members-directory
How to Join OBN. Your Money Working Smarter. Advice & Advocacy. Laboratory & Office Space. How to Join OBN. Your Money Working Smarter. Advice & Advocacy. Laboratory & Office Space. OBN’s Corporate Membership of 400-plus organisations includes many R&D companies (therapeutic, medical technology and diagnostics) as well as an extensive range of contract research (CRO) and manufacturing (CMO) organisations, companies in the associated industries and specialists suppliers. Search for companies by:. Re-usabl...
foresitecapitalmanagement.com
Foresite Capital
http://www.foresitecapitalmanagement.com/portfolio
Since inception in 2011, we have invested in and helped build transformative category-defining companies across the therapeutics, devices,. Diagnostics, and services sectors. AcelRx Pharmaceuticals, Inc. Aduro BioTech (Nasdaq: ADRO) is a clinical stage cancer immuno-oncology company focused on the development of first-in-class technology platforms and products designed to stimulate robust and durable immune responses against cancer. Its lead product candidate, CRS-207, is currently being developed fo...
myelomacrowd.org
More On CAR T Cell Therapy: Hope In Treating Multiple Myeloma - The Myeloma Crowd
http://www.myelomacrowd.org/more-on-car-t-cell-therapy-hope-in-treating-multiple-myeloma
Myeloma – How To GREATLY Improve The High Risk Myeloma Survival Rate! Early Treatment Shows Benefit for Smoldering Myeloma Patients. Our Next Show: Forty Years of Data on MGUS and Smoldering Myeloma with Myeloma Pioneer Dr. Robert Kyle, MD, Mayo Clinic. October 22, Myeloma Crowd Round Tables: Columbus, Ohio. Venetoclax Combination Shows Anti-Myeloma Effects. Utah Multiple Myeloma Symposium at Huntsman Cancer Institute: September 10, 2016. October 15, Myeloma Crowd Round Tables: Baltimore, Maryland. The P...
obn.org.uk
OBN: Supporting the UK’s Innovative Life Sciences Companies | Members Directory (Top Menu)
http://www.obn.org.uk/members-directory
How to Join OBN. Your Money Working Smarter. Advice & Advocacy. Laboratory & Office Space. How to Join OBN. Your Money Working Smarter. Advice & Advocacy. Laboratory & Office Space. Members Directory (Top Menu). OBN’s Corporate Membership of 370-plus organisations includes many R&D companies (therapeutic, medical technology and diagnostics) as well as an extensive range of contract research (CRO) and manufacturing (CMO) organisations, companies in the associated industries and specialists suppliers.
foresitecapital.com
Foresite Capital
http://foresitecapital.com/portfolio
Since inception in 2011, we have invested in and helped build transformative category-defining companies across the therapeutics, devices,. Diagnostics, and services sectors. AcelRx Pharmaceuticals, Inc. Aduro BioTech (Nasdaq: ADRO) is a clinical stage cancer immuno-oncology company focused on the development of first-in-class technology platforms and products designed to stimulate robust and durable immune responses against cancer. Its lead product candidate, CRS-207, is currently being developed fo...